Exosomes derived from gemcitabine-resistant cells transfer malignant phenotypic traits via delivery of miRNA-222-3p

BACKGROUND: Although gemcitabine-based chemotherapy has been established as a core multimodal therapy for non-small cell lung cancer (NSCLC) treatment, its clinical efficacy remains limited by the development of acquired resistance following tumor metastasis and relapse. In this study, we investigat...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Feng, Ma, Chengyuan, Zhou, Tong, Dong, Xuechao, Luo, Qinghua, Geng, Li, Ding, Lijuan, Zhang, Yandong, Zhang, Li, Li, Nan, Li, Yang, Liu, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5526308/
https://www.ncbi.nlm.nih.gov/pubmed/28743280
http://dx.doi.org/10.1186/s12943-017-0694-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5526308/
https://www.ncbi.nlm.nih.gov/pubmed/28743280
http://dx.doi.org/10.1186/s12943-017-0694-8

Ejemplares similares